Study to Compare Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed Synflorix (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants
Phase of Trial: Phase III
Latest Information Update: 19 Jun 2017
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Hib-DTP-hepatitis B vaccine
- Indications Otitis media; Pneumococcal infections; Pneumonia
- Focus Pharmacodynamics; Registrational
- Sponsors GlaxoSmithKline
- 09 Jun 2016 Status changed from active, no longer recruiting to completed.
- 14 Apr 2016 Planned End Date changed from 1 Jul 2016 to 1 Jun 2016.
- 04 Sep 2015 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.